PALISADE CAPITAL MANAGEMENT, LP - DIPLOMAT PHARMACY INC ownership

DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 203 filers reported holding DIPLOMAT PHARMACY INC in Q1 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
PALISADE CAPITAL MANAGEMENT, LP ownership history of DIPLOMAT PHARMACY INC
ValueSharesWeighting
Q4 2018$8,610,000
-29.6%
639,655
+1.5%
0.32%
-6.5%
Q3 2018$12,231,000
-5.6%
630,117
+24.3%
0.34%
-9.9%
Q2 2018$12,953,000
+74.8%
506,783
+37.8%
0.38%
+49.4%
Q1 2018$7,412,000
+61.5%
367,845
+60.9%
0.25%
+61.9%
Q4 2017$4,589,000
+120.0%
228,671
+275.1%
0.16%
+127.9%
Q4 2015$2,086,000
+262.8%
60,960
+204.8%
0.07%
+300.0%
Q3 2015$575,000
+10.8%
20,000
+33.3%
0.02%
+30.8%
Q1 2015$519,00015,0000.01%
Other shareholders
DIPLOMAT PHARMACY INC shareholders Q1 2018
NameSharesValueWeighting ↓
SENZAR ASSET MANAGEMENT, LLC 445,200$7,101,0001.80%
Redmile Group, LLC 1,254,342$20,007,0001.30%
Irving Magee Investment Management 166,505$2,656,0001.02%
BROADVIEW ADVISORS LLC 376,050$5,998,0000.83%
Sivik Global Healthcare LLC 101,000$1,611,0000.75%
FRONTIER CAPITAL MANAGEMENT CO LLC 5,455,461$87,015,0000.64%
Iguana Healthcare Management, LLC 75,000$1,196,0000.59%
RIVERBRIDGE PARTNERS LLC 1,464,286$23,355,0000.47%
HERMES INVESTMENT MANAGEMENT LTD 1,772,777$28,276,0000.46%
Endurant Capital Management LP 85,043$1,356,0000.44%
View complete list of DIPLOMAT PHARMACY INC shareholders